These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial. Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741 [TBL] [Abstract][Full Text] [Related]
4. Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). Ardizzoni A; Tiseo M J Chemother; 2004 Nov; 16 Suppl 4():104-7. PubMed ID: 15688623 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [TBL] [Abstract][Full Text] [Related]
6. Pemetrexed in second-line treatment of non-small-cell lung cancer. De Marinis F; De Petris L Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):38-42. PubMed ID: 15655935 [TBL] [Abstract][Full Text] [Related]
7. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170 [TBL] [Abstract][Full Text] [Related]
8. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057 [TBL] [Abstract][Full Text] [Related]
9. [New cytotoxics in the treatment of bronchial cancers]. Quantin X; Godard P; Michel FB; Pujol JL Rev Mal Respir; 1998 Oct; 15(5):597-612. PubMed ID: 9834987 [TBL] [Abstract][Full Text] [Related]
11. Second-line treatment options in non-small cell lung cancer: a comparison of cytotoxic agents and targeted therapies. de Marinis F; De Santis S; De Petris L Semin Oncol; 2006 Feb; 33(1 Suppl 1):S17-24. PubMed ID: 16472705 [TBL] [Abstract][Full Text] [Related]
12. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer. Ettinger DS Semin Oncol; 2001 Apr; 28(2 Suppl 4):27-9. PubMed ID: 11479894 [TBL] [Abstract][Full Text] [Related]
15. [Advance of second-line chemotherapy in advanced non-small cell lung cancer.]. Zhang L Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):4-9. PubMed ID: 20727256 [TBL] [Abstract][Full Text] [Related]
16. Second- and third-line treatments in non-small cell lung cancer. Kumar A; Wakelee H Curr Treat Options Oncol; 2006 Jan; 7(1):37-49. PubMed ID: 16343367 [TBL] [Abstract][Full Text] [Related]
17. [NSCLC: update on second line therapy following ASCO 2007]. Ploner F Wien Med Wochenschr; 2007; 157(21-22):540-4. PubMed ID: 18157591 [TBL] [Abstract][Full Text] [Related]
18. Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? Gebbia V Expert Opin Pharmacother; 2008 Jun; 9(8):1321-37. PubMed ID: 18473707 [TBL] [Abstract][Full Text] [Related]
19. Treatment of elderly patients with non-small-cell lung cancer. Manegold C Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):46-51. PubMed ID: 11301849 [TBL] [Abstract][Full Text] [Related]